JXR repurchases 1.29 million shares on 21 May; buy-back shares awaiting cancellation reach 33.18 million, representing 1.23% of share capital

Bulletin Express
05/21

Jinxin Fertility Group Limited (JXR) filed a Next Day Disclosure Return outlining the latest progress of its on-market share repurchase programme.

Key takeaways

1. Latest transaction • Date: 21 May 2026 • Shares repurchased: 1.29 million ordinary shares • Price range: HKD 2.28–2.29 per share • Aggregate consideration: HKD 2.96 million

2. Cumulative repurchases pending cancellation • Between 27 March and 21 May 2026, JXR bought back 33.18 million shares for cancellation that have not yet been cancelled. • These shares equal 1.23 % of the company’s 2.71 billion issued shares outstanding as of 21 May 2026.

3. Share capital position • Opening and closing issued share count (excluding shares pending cancellation): 2.71 billion. • No new shares were issued during the period covered by the return.

4. Repurchase mandate utilisation • Shares authorised for repurchase: 274.47 million (shareholder mandate dated 26 June 2025). • Shares repurchased under the mandate to date: 72.84 million, representing 2.65 % of the share count at the time the mandate was granted.

5. Moratorium on new share issues Under Hong Kong Listing Rule 10.06(3)(a), JXR may not issue new shares until 20 June 2026 following the latest buy-back.

The filing confirms that all repurchases were executed in accordance with the Hong Kong Listing Rules and the company’s shareholder mandate.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10